Trial intelligence / Profile preview

Intra-arterial nimodipine for cerebral vasospasm after aneurysmal subarachnoid hemorrhage

TCTR20200121002Phase 2Completed

Start
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of nimodipine in cerebral vasospasm and subarachnoid hemorrhage (SAH) (2 arms), sponsored by None. Started Jun 2016; status: completed.

02

Drugs

nimodipine
03

Conditions

cerebral vasospasmsubarachnoid hemorrhage (SAH)

Beyond the preview

Go deeper on TCTR20200121002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200121002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call